5Riesco-Eizaguirre G ,Santisteban P. New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy[J]. Endocr Relat Canc- er,2007 ; 14(4) :957-77.
6Zanetti A, Stoppacciaro A, Marzullo A, et al. Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid[ J]. J Pathol, 1998 ; 186 (3) :287-91.
7Luna-More S, Gonzalez B, Acedo C, et al. Invasive micropapillary carcino- ma of the breast. A new special type of invasive mammary carcinoma [ J ]. Pathol Res Pract, 1994 ; 190 (7) :668-74.
8Nardone HC, Ziober AF, LiVolsi VA, et al. c-Met expression in tall cell variant papillary carcinoma of the thyroid [ J ]. Cancer, 2003 ; 98 ( 7 ) :1386-93.
9Ruco LP, Stoppacciaro A, Ballarini F, et al. Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid : evidence for a pathogenetic role in tumourigenesis [ J ]. J Pathol, 2001 ; 194 ( 1 ) :4 -8.
10Herynk MH, Zhang J, Parikh NU,et al. Activation of Src by c-Met overex- pression mediates metastatic properties of colorectal carcinoma cells(J). J Exp Ther Oncol,2007 ;6(3 ) :205-17.
